Korea Extends Closely Watched Pilot Project For Rare Disease Drug Refunds Three More Years
This article was originally published in PharmAsia News
Executive Summary
To maintain a stable supply of some multinational products for patients with rare diseases, the health ministry has extended its pilot refund system for three more years until 2015.